Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dose Timing of Coupled Intravesical Gentamicin and Lactobacillus Rhamnosus LGG on Success and Length of Colonization in Men and Women With SCI/D and NLUTD

NCT07643974 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT07643974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07643974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dose Timing of Coupled Intravesical Gentamicin and Lactobacillus Rhamnosus LGG on Success and Length of Colonization in Men and Women With SCI/D and NLUTD
Lead sponsor
Medstar Health Research Institute
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
September 30, 2027
Enrollment
48 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, neurogenic bladder (nb), neurogenic lower urinary tract dysfunction, spina bifida, spinal cord injury, urinary tract infection(uti)